These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 34097189)
41. Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer. Katainen R; Donner I; Cajuso T; Kaasinen E; Palin K; Mäkinen V; Aaltonen LA; Pitkänen E Nat Protoc; 2018 Nov; 13(11):2580-2600. PubMed ID: 30323186 [TBL] [Abstract][Full Text] [Related]
42. De novo discovery of mutated driver pathways in cancer. Vandin F; Upfal E; Raphael BJ Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252 [TBL] [Abstract][Full Text] [Related]
43. Characterization of germline mutations in familial lung cancer from the Chinese population. Kanwal M; Ding XJ; Ma ZH; Li LW; Wang P; Chen Y; Huang YC; Cao Y Gene; 2018 Jan; 641():94-104. PubMed ID: 29054765 [TBL] [Abstract][Full Text] [Related]
44. Molecular genetics of AML. Link DC Best Pract Res Clin Haematol; 2012 Dec; 25(4):409-14. PubMed ID: 23200536 [TBL] [Abstract][Full Text] [Related]
45. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network. Pei G; Hu R; Dai Y; Zhao Z; Jia P Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130 [TBL] [Abstract][Full Text] [Related]
46. Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer. Rao Y; Ahmed N; Pritchard J; O'Brien EP BMC Bioinformatics; 2023 Dec; 24(1):462. PubMed ID: 38062391 [TBL] [Abstract][Full Text] [Related]
47. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma. Wrzeszczynski KO; Felice V; Shah M; Rahman S; Emde AK; Jobanputra V; O Frank M; Darnell RB Methods Mol Biol; 2018; 1741():1-29. PubMed ID: 29392687 [TBL] [Abstract][Full Text] [Related]
48. A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types. Cheng F; Liu C; Lin CC; Zhao J; Jia P; Li WH; Zhao Z PLoS Comput Biol; 2015 Sep; 11(9):e1004497. PubMed ID: 26352260 [TBL] [Abstract][Full Text] [Related]
49. Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types. Ghareyazi A; Kazemi A; Hamidieh K; Dashti H; Tahaei MS; Rabiee HR; Alinejad-Rokny H; Dehzangi I BMC Bioinformatics; 2022 Jul; 23(1):298. PubMed ID: 35879674 [TBL] [Abstract][Full Text] [Related]
50. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations. Sun S; Thorson JA; Murray SS Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720 [TBL] [Abstract][Full Text] [Related]
51. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers. Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364 [TBL] [Abstract][Full Text] [Related]
52. A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events. Li J; Poursat MA; Drubay D; Motz A; Saci Z; Morillon A; Michiels S; Gautheret D PLoS Comput Biol; 2015 Nov; 11(11):e1004583. PubMed ID: 26588488 [TBL] [Abstract][Full Text] [Related]
54. Public attitudes in Japan toward participation in whole genome sequencing studies. Okita T; Ohashi N; Kabata D; Shintani A; Kato K Hum Genomics; 2018 Apr; 12(1):21. PubMed ID: 29653595 [TBL] [Abstract][Full Text] [Related]
55. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Barbieri CE; Demichelis F; Rubin MA Histopathology; 2012 Jan; 60(1):187-98. PubMed ID: 22212086 [TBL] [Abstract][Full Text] [Related]
56. pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing. Thutkawkorapin J; Eisfeldt J; Tham E; Nilsson D BMC Bioinformatics; 2020 Apr; 21(1):128. PubMed ID: 32245405 [TBL] [Abstract][Full Text] [Related]
57. Defining the clinical genomic landscape for real-world precision oncology. Beer PA; Cooke SL; Chang DK; Biankin AV Genomics; 2020 Nov; 112(6):5324-5330. PubMed ID: 33144218 [TBL] [Abstract][Full Text] [Related]
58. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis. Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526 [TBL] [Abstract][Full Text] [Related]
59. Research and clinical applications of cancer genome sequencing. Ku CS; Cooper DN; Ziogas DE; Halkia E; Tzaphlidou M; Roukos DH Curr Opin Obstet Gynecol; 2013 Feb; 25(1):3-10. PubMed ID: 23108289 [TBL] [Abstract][Full Text] [Related]
60. Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines. Chang H; Jackson DG; Kayne PS; Ross-Macdonald PB; Ryseck RP; Siemers NO PLoS One; 2011; 6(6):e21097. PubMed ID: 21701589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]